Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
61.50
+0.70 (1.15%)
Aug 27, 2026, 5:35 PM CET

BME:ROVI Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
126.9797.9827.1925.32124.9599.04
Short-Term Investments
1.10.620.830.110.090.1
Cash & Short-Term Investments
128.0798.628.0225.44125.0399.14
Cash Growth
168.53%251.93%10.15%-79.66%26.13%86.22%
Accounts Receivable
147.7163.31114.83124.55160.23129.8
Other Receivables
12.3112.0412.6115.9121.0627.83
Receivables
160175.36127.44140.46181.28157.63
Inventory
272.81287.98329.95337.97311.94245.47
Prepaid Expenses
4.643.192.692.732.031.79
Other Current Assets
2.431.591.512.742.792.33
Total Current Assets
567.96566.71489.61509.33623.07506.36
Property, Plant & Equipment
485.64330.74286.62253.65215.54181.78
Long-Term Investments
19.2519.1619.520.592.22.07
Goodwill
2.72.7----
Other Intangible Assets
32.9933.1833.9527.7429.1431.51
Long-Term Deferred Tax Assets
18.483.22.262.342.083.85
Long-Term Deferred Charges
---6.166.67.05
Other Long-Term Assets
--0.070.070.070.07
Total Assets
1,127955.69832.02799.88878.7732.68

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
73.0284.7589.93109.89125.8799.4
Accrued Expenses
37.9630.2333.1928.8331.6724.6
Current Portion of Long-Term Debt
27.1522.2617.848.068.272.98
Current Portion of Leases
-6.365.855.134.463.44
Current Income Taxes Payable
34.884.42.385.26-0.68
Current Unearned Revenue
37.8129.645.2539.51115.3958.12
Other Current Liabilities
65.733.582.213.178.231.17
Total Current Liabilities
276.55181.22156.65199.84293.89190.39
Long-Term Debt
80.5483.8880.538.5846.0452.52
Long-Term Leases
-9.3310.2213.6713.414.22
Long-Term Unearned Revenue
30.925.462.752.793.323.79
Long-Term Deferred Tax Liabilities
21.770.160.371.520.680.78
Other Long-Term Liabilities
0.20.19----
Total Liabilities
409.97280.24250.48256.39357.32261.7

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3.073.073.073.243.243.36
Additional Paid-In Capital
87.6487.6487.6487.6487.6487.64
Retained Earnings
614.12578.93486.89556.21456.7446.1
Treasury Stock
-5.85-5.17-5.55-107.68-27.56-66.12
Comprehensive Income & Other
1.64-0.05-0.02-0.02-0.01-0
Total Common Equity
700.62664.42572.03539.39520.01470.98
Minority Interest
16.4311.049.514.111.37-
Shareholders' Equity
717.05675.46581.54543.49521.38470.98
Total Liabilities & Equity
1,127955.69832.02799.88878.7732.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
107.69121.82114.4165.4372.1773.16
Net Cash (Debt)
20.38-23.22-86.39-39.9952.8725.97
Net Cash Growth
----103.55%-
Net Cash Per Share
0.40-0.45-1.69-0.750.990.47
Filing Date Shares Outstanding
51.1451.1551.1551.8253.3754.85
Total Common Shares Outstanding
51.1451.1551.1551.8253.3754.85
Working Capital
291.41385.49332.96309.49329.19315.97
Book Value Per Share
13.7012.9911.1810.419.748.59
Tangible Book Value
664.93628.53538.08511.65490.87439.46
Tangible Book Value Per Share
13.0012.2910.529.879.208.01
Land
211.1981.7974.860.6545.1237.25
Machinery
469.29445.19404.19372.97303.78275.44
Construction In Progress
31.1722.0911.018.4740.1728.06